These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 35400105)

  • 1. Pharmacodynamic Parameters of Pharmacokinetic/Pharmacodynamic (PK/PD) Integration Models.
    Zhang L; Xie H; Wang Y; Wang H; Hu J; Zhang G
    Front Vet Sci; 2022; 9():860472. PubMed ID: 35400105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetic/pharmacodynamic paradigm for antimicrobial drugs in veterinary medicine: Recent advances and critical appraisal.
    Toutain PL; Pelligand L; Lees P; Bousquet-Mélou A; Ferran AA; Turnidge JD
    J Vet Pharmacol Ther; 2021 Mar; 44(2):172-200. PubMed ID: 33089523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New concept and a theoretical consideration of the mechanism-based pharmacokinetics/ pharmacodynamics (PK/PD) modeling for antimicrobial agents.
    Sato N; Suzuki H; Hayashi H; Shibasaki S; Sugano T; Maebashi K; Kurosawa T; Shiomi M; Ogata H
    Jpn J Antibiot; 2008 Oct; 61(5):314-38. PubMed ID: 19260351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic-Pharmacodynamic Modeling of Enrofloxacin Against Escherichia coli in Broilers.
    Sang K; Hao H; Huang L; Wang X; Yuan Z
    Front Vet Sci; 2015; 2():80. PubMed ID: 26779495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization.
    Nielsen EI; Cars O; Friberg LE
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4619-30. PubMed ID: 21807983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine.
    Toutain PL
    AAPS PharmSci; 2002; 4(4):E38. PubMed ID: 12646010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation of a rational dosage regimen of ceftiofur hydrochloride oily suspension by pharmacokinetic-pharmacodynamic (PK-PD) model for treatment of swine
    Luo W; Wang D; Qin H; Chen D; Pan Y; Qu W; Huang L; Xie S
    J Vet Sci; 2021 Nov; 22(6):e41. PubMed ID: 34854264
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Huang Z; Wu Y; Zhou Z; Xia X; Gu X; Cai Q; Shen X; Yang H; Ding H
    Front Pharmacol; 2019; 10():670. PubMed ID: 31293418
    [No Abstract]   [Full Text] [Related]  

  • 9. Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine.
    Toutain PL; Lees P
    J Vet Pharmacol Ther; 2004 Dec; 27(6):467-77. PubMed ID: 15601441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Semi-Mechanistic Pharmacokinetic and Pharmacodynamic Model in Antimicrobial Resistance.
    Mi K; Zhou K; Sun L; Hou Y; Ma W; Xu X; Huo M; Liu Z; Huang L
    Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35213979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic testing of marbofloxacin administered as a single injection for the treatment of bovine respiratory disease.
    Vallé M; Schneider M; Galland D; Giboin H; Woehrlé F
    J Vet Pharmacol Ther; 2012 Dec; 35(6):519-28. PubMed ID: 22126438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of pharmacokinetic/pharmacodynamic modeling and simulation in the development of new anti-infective agents - minimum inhibitory concentration versus time-kill curves.
    Schmidt S; Schuck E; Kumar V; Burkhardt O; Derendorf H
    Expert Opin Drug Discov; 2007 Jun; 2(6):849-60. PubMed ID: 23489002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic modeling and simulation for bactericidal effect in an in vitro dynamic model.
    Katsube T; Yano Y; Yamano Y; Munekage T; Kuroda N; Takano M
    J Pharm Sci; 2008 Sep; 97(9):4108-17. PubMed ID: 18314887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dose regimen formulation of tilmicosin against Lawsonia intracellularis in pigs by pharmacokinetic-pharmacodynamic (PK-PD) model.
    Luo W; Qin H; Chen D; Wu M; Meng K; Zhang A; Pan Y; Qu W; Xie S
    Microb Pathog; 2020 Oct; 147():104389. PubMed ID: 32707311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose Optimization of Combined Linezolid and Fosfomycin against
    Mao J; Li T; Zhang N; Wang S; Li Y; Peng Y; Liu H; Yang G; Yan Y; Jiang L; Liu Y; Li J; Huang X
    Microbiol Spectr; 2021 Dec; 9(3):e0087121. PubMed ID: 34851157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose Optimization of Aditoprim-Sulfamethoxazole Combinations Against
    Maan MK; Chaudhry TH; Sattar A; Shabbir MAB; Ahmed S; Mi K; Ahmed W; Xie S; Xin L; Huang L
    Front Pharmacol; 2021; 12():753359. PubMed ID: 34867364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine Thigh Microdialysis to Evaluate the Pharmacokinetic/Pharmacodynamic Integration of Cefquinome Against
    Zhang L; Zhou Z; Gu X; Huang S; Shen X; Ding H
    Front Vet Sci; 2020; 7():448. PubMed ID: 32851028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic-pharmacodynamic integration and modelling of oxytetracycline administered alone and in combination with carprofen in calves.
    Brentnall C; Cheng Z; McKellar QA; Lees P
    Res Vet Sci; 2013 Jun; 94(3):687-94. PubMed ID: 23415880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A proposal of a pharmacokinetic/pharmacodynamic (PK/PD) index map for selecting an optimal PK/PD index from conventional indices (AUC/MIC, Cmax/MIC, and TAM) for antibiotics.
    Kitamura Y; Yoshida K; Kusama M; Sugiyama Y
    Drug Metab Pharmacokinet; 2014; 29(6):455-62. PubMed ID: 25008846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant prevention concentration-based pharmacokinetic/pharmacodynamic indices as dosing targets for suppressing the enrichment of levofloxacin-resistant subpopulations of Staphylococcus aureus.
    Liang B; Bai N; Cai Y; Wang R; Drlica K; Zhao X
    Antimicrob Agents Chemother; 2011 May; 55(5):2409-12. PubMed ID: 21343454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.